US food benefits for the poor to be reduced as pandemic provisions end

Published Date: 02 Mar 2023

As the federal government ends pre-approved benefits during the early stages of the COVID-19 pandemic, low-income Americans could receive less food assistance or lose their eligibility altogether.

Read Full News

Latest News

Trump Administration Appeals Judge's Order Upending Kennedy's Vaccine Policies

The Trump administration on Wednesday appealed a federal judge's ruling blocking key elements of Health Secretary Robert F. Kennedy Jr.'s push to reshape U.S. vaccine...

Next-Gen Sequencing Detects Neoplastic Bile Duct Strictures

DNA/RNA-based next-generation sequencing allows earlier diagnosis of neoplastic bile duct strictures, a prospective multicenter real-time study finds.

Drug-Resistant Salmonella Surfaces Risk of Backyard Poultry

Expert highlights need for better surveillance and smart antibiotic use to prevent future outbreaks.

Multiple Anti‑TNF Switches Durable, Safe in Paediatric IBD

Multiple intramolecular switches among anti-TNF agents in children with inflammatory bowel disease show no clinically meaningful decline in treatment durability or increase in adverse events.

FDA OKs Daraxonrasib Pancreatic Cancer Preapproval Access

FDA authorizes an expanded access treatment protocol after the oral RAS(ON) inhibitor doubled survival for metastatic patients in a phase 3 trial.

NSAID Use Not Tied to Hospitalization in Ulcerative Colitis

Use of NSAIDs is not associated with an increased risk for disease-related hospitalization in ulcerative colitis, although a small increase is observed in Crohn’s disease.

Todays Updates

Baveno Criteria May Reduce Endoscopy Burden in Cirrhosis

The Baveno VI criteria show high sensitivity for ruling out clinically significant portal hypertension and high-risk varices in patients with cirrhosis.

Todays Updates

Baveno Criteria May Reduce Endoscopy Burden in Cirrhosis

The Baveno VI criteria show high sensitivity for ruling out clinically significant portal hypertension and high-risk varices in patients with cirrhosis.

Latest News

The Trump administration on Wednesday appealed a federal judge's ruling blocking key elements of Health Secretary Robert F. Kennedy Jr.'s push to reshape U.S. vaccine...

DNA/RNA-based next-generation sequencing allows earlier diagnosis of neoplastic bile duct strictures, a prospective multicenter real-time study finds.

Expert highlights need for better surveillance and smart antibiotic use to prevent future outbreaks.

Multiple intramolecular switches among anti-TNF agents in children with inflammatory bowel disease show no clinically meaningful decline in treatment durability or increase in adverse events.

FDA authorizes an expanded access treatment protocol after the oral RAS(ON) inhibitor doubled survival for metastatic patients in a phase 3 trial.

Use of NSAIDs is not associated with an increased risk for disease-related hospitalization in ulcerative colitis, although a small increase is observed in Crohn’s disease.

News All Time

Vitamin C’s Potential Use in Cancer Is Getting a Second Look

Decades after early trials seemed to close the book on vitamin C as a cancer treatment, a member of a group of determined researchers is receiving the therapy himself.

Education Gap Tied to Higher Risk for Young-Onset CRC Death

Researchers analyze trends in colorectal cancer mortality among adults aged 25-49 years in a study spanning about three decades.

Aspirin Unlikely to Cut Colorectal Cancer Incidence

A Cochrane Review finds aspirin likely results in little to no diﬀerence in colorectal cancer incidence at a follow-up of 5 years to less than 15 years.

Tumor Genomic Testing: Too Little, Too Late

Tumor genomic testing is critical to informed treatment decisions, but researchers find that it’s used in too few patients and often too late.

High-Impact Exercise Linked to Anal Incontinence in Women

High-impact sports may increase the risk for anal incontinence, especially among women, with many cases underdiagnosed because of stigma and low awareness.

Spyre's Inflammatory Bowel Drug Shown to Reduce Disease Activity in Mid-stage Study

Spyre Therapeutics said on Monday its experimental drug showed a significant reduction in disease activity when ⁠tested in patients with ulcerative colitis in a mid-stage...

Age and Visceral Fat May Trend Together: What to Know

Why fat that surrounds organs is more dangerous continues to be studied.

Vaccination Protects Young Men From HPV-Related Cancers

HPV-related cancers — including anal, penile, and oropharyngeal — are rare in people younger than 50, but new research suggests vaccinated boys could see cancer protection in their teens and 20s.

The Intersection Between Gut and Spine Health

Emerging research is showing more and more connection between the two.

IBD Flare Prediction Improved by Psychosocial Data

Predictive models that combine patient-reported psychosocial measures with clinical data perform well in forecasting flares in patients with inflammatory bowel disease.

Sacral Fracture Risk After Short-Course RT for Rectal Cancer

A recent retrospective analysis assesses the incidence and risk factors for sacral fractures among patients receiving short-course radiation therapy for rectal cancer.

Heavy Drinking Tied to Young-Onset Pancreatic Cancer

A nationwide Korean cohort study of more than 6.2 million young adults found an association between heavy alcohol use and pancreatic cancer risk before age 50.

How Gut Bacteria Could Trigger Memory Loss as We Age

Researchers found potential links between gut bacteria and memory loss, with gut-brain connections triggering loss of memory encoding in the hippocampus.

AstraZeneca's Liver Cancer Therapy Combo Slows Disease Progression in Late-stage Trial

AstraZeneca said on Thursday that a combination treatment with its cancer drug Imfinzi showed significant improvement in ⁠how long patients with a common liver cancer lived...

Symptom-Based H pylori Testing Does Not Prevent Cancer

Most gastric cancers found in people diagnosed with H pylori may already be present at diagnosis, and treatment of the infection may not provide short-term protection.